Altria Group Inc. Chief Executive Marty Barrington is retiring and will be replaced by another 25-year company veteran. Mr. Barrington, who has held the top post for six years, will retire in May after a quarter of a century with the tobacco company, Altria said Thursday. His replacement is Howard Willard, 54, the company's current operating chief and former finance chief.
ApidraÂ® (insulin glulisine) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes in adults. It is a rapid-acting insulin used to help control the spike in blood sugar levels that occurs after meals. It is typically used in combination with a long-acting insulin.
Insulin glulisine. Insulin glulisine is a rapid-acting insulin analogue that differs from human insulin in that the amino acid asparagine at position B3 is replaced by lysine and the lysine in position B29 is replaced by glutamic acid. It was developed by Sanofi-Aventis and is sold under the trade name Apidra.